244 related articles for article (PubMed ID: 22123932)
1. History and current concepts in the pathogenesis of PML.
Major EO
Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S3-7. PubMed ID: 22123932
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression increases JC polyomavirus large T antigen DNA load in the brains of patients without progressive multifocal leukoencephalopathy.
Bayliss J; Karasoulos T; McLean CA
J Infect Dis; 2013 Jan; 207(1):133-6. PubMed ID: 23112281
[TBL] [Abstract][Full Text] [Related]
3. The effect of plasma exchange on serum anti-JC virus antibodies.
Subramanyam M; Plavina T; Khatri BO; Fox RJ; Goelz SE
Mult Scler; 2013 Jun; 19(7):912-9. PubMed ID: 23232602
[TBL] [Abstract][Full Text] [Related]
4. Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy.
Sabath BF; Major EO
J Infect Dis; 2002 Dec; 186 Suppl 2():S180-6. PubMed ID: 12424695
[TBL] [Abstract][Full Text] [Related]
5. A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
Lee P; Plavina T; Castro A; Berman M; Jaiswal D; Rivas S; Schlain B; Subramanyam M
J Clin Virol; 2013 Jun; 57(2):141-6. PubMed ID: 23465394
[TBL] [Abstract][Full Text] [Related]
6. New JC virus infection patterns by in situ polymerase chain reaction in brains of acquired immunodeficiency syndrome patients with progressive multifocal leukoencephalopathy.
von Einsiedel RW; Samorei IW; Pawlita M; Zwissler B; Deubel M; Vinters HV
J Neurovirol; 2004 Feb; 10(1):1-11. PubMed ID: 14982723
[TBL] [Abstract][Full Text] [Related]
7. Advances in the management of PML: focus on natalizumab.
Fox R
Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S33-7. PubMed ID: 22123933
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppression increases latent infection of brain by JC polyomavirus.
Bayliss J; Karasoulos T; Bowden S; Glogowski I; McLean CA
Pathology; 2011 Jun; 43(4):362-7. PubMed ID: 21532525
[TBL] [Abstract][Full Text] [Related]
9. [Simultaneous in situ detection of JC virus antigens and RNA in progressive multifocal leukoencephalopathy (PML) by immunocytochemistry and in situ hybridization].
Nakamura S; Yoshioka M; Nagano I; Shimazaki S; Kogure K
Rinsho Shinkeigaku; 1990 Mar; 30(3):266-71. PubMed ID: 2163786
[TBL] [Abstract][Full Text] [Related]
10. JCV detection in multiple sclerosis patients treated with natalizumab.
Sadiq SA; Puccio LM; Brydon EW
J Neurol; 2010 Jun; 257(6):954-8. PubMed ID: 20052484
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.
Bossolasco S; Calori G; Moretti F; Boschini A; Bertelli D; Mena M; Gerevini S; Bestetti A; Pedale R; Sala S; Sala S; Lazzarin A; Cinque P
Clin Infect Dis; 2005 Mar; 40(5):738-44. PubMed ID: 15714422
[TBL] [Abstract][Full Text] [Related]
12. JC virus infection in cells from lymphoid tissue.
Monaco MC; Shin J; Major EO
Dev Biol Stand; 1998; 94():115-22. PubMed ID: 9776232
[TBL] [Abstract][Full Text] [Related]
13. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
[TBL] [Abstract][Full Text] [Related]
14. Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort.
Trampe AK; Hemmelmann C; Stroet A; Haghikia A; Hellwig K; Wiendl H; Goelz S; Ziegler A; Gold R; Chan A
Neurology; 2012 May; 78(22):1736-42. PubMed ID: 22592369
[TBL] [Abstract][Full Text] [Related]
15. The clinical utility of JC virus antibody index measurements in the context of progressive multifocal leukoencephalopathy.
Reuwer AQ; Heron M; van der Dussen D; Schneider-Hohendorf T; Murk JL
Acta Neurol Scand; 2017 Nov; 136 Suppl 201():37-44. PubMed ID: 29068484
[TBL] [Abstract][Full Text] [Related]
16. Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy.
Tornatore C; Berger JR; Houff SA; Curfman B; Meyers K; Winfield D; Major EO
Ann Neurol; 1992 Apr; 31(4):454-62. PubMed ID: 1316734
[TBL] [Abstract][Full Text] [Related]
17. Anti-JC virus antibodies: implications for PML risk stratification.
Gorelik L; Lerner M; Bixler S; Crossman M; Schlain B; Simon K; Pace A; Cheung A; Chen LL; Berman M; Zein F; Wilson E; Yednock T; Sandrock A; Goelz SE; Subramanyam M
Ann Neurol; 2010 Sep; 68(3):295-303. PubMed ID: 20737510
[TBL] [Abstract][Full Text] [Related]
18. Modeling probability of additional cases of natalizumab-associated JCV sero-negative progressive multifocal leukoencephalopathy.
Carruthers RL; Chitnis T; Healy BC
Mult Scler; 2014 May; 20(6):757-60. PubMed ID: 24189572
[TBL] [Abstract][Full Text] [Related]
19. Progressive multifocal leukoencephalopathy: JC virus induced demyelination in the immune compromised host.
Hou J; Major EO
J Neurovirol; 2000 May; 6 Suppl 2():S98-S100. PubMed ID: 10871795
[TBL] [Abstract][Full Text] [Related]
20. A review on JC virus infection in kidney transplant recipients.
Delbue S; Ferraresso M; Ghio L; Carloni C; Carluccio S; Belingheri M; Edefonti A; Ferrante P
Clin Dev Immunol; 2013; 2013():926391. PubMed ID: 23424601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]